The study was led by researchers at the University of São Paulo in Brazil and utilized data from the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). By analyzing the dietary habits and cognitive performance of 12,772 participants, the research team found that those with the highest intake of specific sweeteners experienced a decline in cognitive abilities that was 62% faster than those with the lowest intake. This accelerated decline was estimated to be equivalent to an additional 1.6 years of biological brain aging over the study’s duration.
Methodology and the ELSA-Brasil Cohort
The ELSA-Brasil study is one of the largest and most robust longitudinal health studies conducted in South America, designed to investigate the incidence and risk factors for chronic diseases. For this specific analysis, participants had an average age of 52 at the start of the monitoring period. The cohort was diverse, representing a broad cross-section of the adult population living in various regions of Brazil.
To establish a baseline, participants completed extensive food frequency questionnaires (FFQs). These validated tools required individuals to recall and report their consumption of hundreds of food items and beverages over the previous 12 months. Researchers specifically targeted seven common sweeteners: aspartame, saccharin, acesulfame K, erythritol, xylitol, sorbitol, and tagatose. These ingredients are standard fixtures in the modern diet, found in everything from diet sodas and flavored waters to "light" yogurts, sugar-free desserts, and tabletop sweeteners used in coffee and tea.
Participants were categorized into three tiers based on their total daily intake. The lowest consumption group averaged just 20 milligrams per day (mg/day), representing occasional or minimal use. The middle group showed higher regular usage, while the highest group averaged 191 mg/day. To put these numbers into perspective, the amount of aspartame in the high-consumption group was roughly equivalent to the amount found in a single 12-ounce can of diet soda. This suggests that even moderate daily consumption, by modern dietary standards, could place an individual in the highest risk category identified by the study.
Assessing Brain Health and Cognitive Performance
The primary objective of the study was to measure changes in cognitive function over time. Participants underwent standardized cognitive assessments at three distinct points: the beginning of the study, a midpoint, and at the eight-year conclusion. These tests were designed to measure a variety of neurological domains:
- Verbal Fluency: The ability to retrieve and produce words rapidly, which is often an early indicator of executive function health.
- Working Memory: The brain’s "short-term" system responsible for holding and manipulating information for immediate tasks.
- Word Recall: A measure of episodic memory, which involves the ability to learn and remember new information.
- Processing Speed: A metric reflecting how quickly the central nervous system can understand and respond to incoming information.
The results were stark. After adjusting for confounding variables such as age, sex, educational level, smoking status, physical activity, and pre-existing conditions like hypertension and cardiovascular disease, the correlation remained robust. The middle consumption group experienced a 35% faster decline in overall cognition compared to the lowest group—a difference equivalent to 1.3 years of aging. The highest group, as noted, faced a 62% faster decline.
The Role of Diabetes and Age Demographics
One of the most significant findings of the research was the disproportionate impact on two specific groups: people with diabetes and adults under the age of 60.
For individuals with diabetes, the association between sweetener intake and cognitive decline was notably stronger. Dr. Claudia Kimie Suemoto, MD, PhD, the study’s lead author from the University of São Paulo, noted that people with diabetes are often the primary consumers of artificial sweeteners. "People with diabetes are frequently advised to avoid refined sugars to manage their blood glucose levels," Suemoto explained. "Consequently, they may turn to these substitutes in much higher volumes. Our findings suggest that this dietary shift, while intended to manage one health issue, might inadvertently contribute to another—accelerated brain aging."
Furthermore, the data revealed an age-dependent effect. Among participants younger than 60, high sweetener consumption was linked to faster declines in verbal fluency and total cognitive scores. Interestingly, this same association was not statistically significant among participants over the age of 60. This suggests that the middle-age window may be a critical period where dietary choices have a more pronounced impact on long-term neurological trajectories, or perhaps that the cumulative effects of these additives manifest more clearly when introduced earlier in the aging process.
Analysis of Individual Sweeteners
While the study looked at total intake, it also isolated the effects of individual sweeteners. Of the seven examined, six were linked to faster cognitive decline, particularly in the realm of memory. These included:
- Aspartame: Commonly used in diet beverages and "Equal."
- Saccharin: Found in "Sweet’N Low."
- Acesulfame K: Often blended with other sweeteners to mask bitter aftertastes.
- Erythritol, Xylitol, and Sorbitol: Sugar alcohols frequently used in sugar-free gum, candies, and "keto-friendly" baked goods.
Tagatose was the only sweetener included in the study that did not show a correlation with cognitive decline. Tagatose is a functional sweetener that is chemically similar to fructose but has a lower glycemic index and fewer calories. However, it is less commonly used in the mass market compared to aspartame or saccharin, which may have influenced the data.
Biological Context and Global Health Trends
The findings in Neurology contribute to a growing body of evidence questioning the safety and efficacy of non-sugar sweeteners (NSS). In 2023, the World Health Organization (WHO) issued a conditional guideline recommending against the use of NSS to control body weight or reduce the risk of non-communicable diseases. The WHO noted that while these substitutes may reduce calorie intake in the short term, they do not offer long-term benefits for body fat reduction and may increase the risk of type 2 diabetes and cardiovascular diseases.
The biological mechanisms through which sweeteners might affect the brain are still being debated. Some researchers hypothesize that certain sweeteners may disrupt the gut microbiome, which is intrinsically linked to brain health through the "gut-brain axis." Others suggest that the intense sweetness of these products, without the accompanying calories, may confuse the brain’s metabolic signaling, leading to inflammation or altered insulin sensitivity in the brain—factors known to contribute to cognitive impairment.
Moreover, the presence of these sweeteners is often a marker for the consumption of ultra-processed foods (UPFs). UPFs are industrial formulations that contain little to no whole foods and are high in additives. Previous studies have linked high UPF consumption to a range of negative health outcomes, including obesity, cancer, and dementia.
Limitations and Future Research
Despite the compelling nature of the data, the researchers emphasized that the study was observational. This means it identified a correlation but did not prove that the sweeteners caused the cognitive decline. Other lifestyle factors or "reverse causality"—where individuals already experiencing subtle cognitive changes might change their diets—cannot be entirely ruled out.
Additionally, the study relied on self-reported dietary data. "Self-reporting is always a limitation in nutritional epidemiology," said Dr. Suemoto. "People may under-report their intake of certain foods or simply forget what they consumed over the course of a year."
The study also did not include newer or "natural" low-calorie sweeteners like Stevia or Monk fruit, which have gained popularity in recent years. Therefore, the results cannot be generalized to all sugar substitutes currently on the market.
Implications for Public Health and Consumer Choice
The findings present a challenge for public health officials and consumers alike. For decades, artificial sweeteners have been promoted as a "free pass" for those wishing to enjoy sweet flavors without the metabolic cost of sugar. This study suggests that the cost may simply be shifted from metabolic health to neurological health.
Dr. Suemoto and her team argue that more research is needed to determine if other alternatives—such as small amounts of honey, maple syrup, or fruit-based sweeteners like applesauce—might be safer options for those looking to reduce refined sugar. "The goal is to find a balance," Suemoto added. "We need to understand if the brain processes these ‘natural’ alternatives differently than synthetic or highly refined sugar alcohols."
As the global population ages and the prevalence of dementia and Alzheimer’s disease continues to rise, identifying modifiable risk factors like diet becomes a matter of urgent public priority. For now, the researchers suggest that moderation is key, and that a return to whole, minimally processed foods may be the most effective strategy for preserving cognitive vitality well into old age.
The research was supported by the Brazilian Ministry of Health, the Ministry of Science, Technology, and Innovation, and the National Council for Scientific and Technological Development. These institutions continue to monitor the ELSA-Brasil cohort, with future reports expected to dive deeper into the relationship between nutrition and the long-term prevention of chronic neurological conditions.
